Clinical Trial Update: Evaluation of Individual Bioequivalence of Gabasandoz® Relative to Neurontin® in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing Gabasandoz to Neurontin (gabapentin) in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Neuropathic Pain

Drugs mentioned

• Gabasandoz (gabapentin)
• NEURONTIN (gabapentin)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Epilepsy and Neuropathic Pain | Phase 1 | Status: COMPLETED